Diagnosis and treatment outcomes for patients with lymphoma of the parotid gland
E Wyss(University of Bern), A. Arnold(University of Bern), Daniel Rauch(Washington University in St. Louis), Peter Zbären(University of Bern), Pirus Ghadjar(Humboldt-Universität zu Berlin), Esther Mueller‐Garamvölgyi(University of Bern)
Cited by 17
Related Papers
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial
|The Lancet|2015|392
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
|The Lancet Respiratory Medicine|2017|184
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
|Annals of Oncology|2016|140